Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Key facts

Sponsor

University of California, Irvine

Principal Investigator

Alexandre Chan, PharmD, MPH

Chao Family Comprehensive Cancer Center

Intervention

Riluzole(drug)

Enrollment

51 target

Eligibility

18 years · All sexes

Timeline

2024 – 2027

Study locations (1)

• Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, California, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Sarcoma of cervix uteri

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07071727
  Short Course of Radiotherapy Prior to Surgery of Soft Tissue Sarcomas
  The Netherlands Cancer Institute
• RECRUITINGPHASE2NCT07192068
  Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.
  UNICANCER
• RECRUITINGPHASE1NCT06771219
  SLV-154 Treatment of Metastatic Solid Tumors
  Solve Therapeutics
• RECRUITINGNCT06904365
  Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
  Washington University School of Medicine
• RECRUITINGNANCT06103669
  Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)
  University of California, Davis
• RECRUITINGNCT05366881
  cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
  Adela, Inc
• RECRUITINGPHASE1, PHASE2NCT05187338
  Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
  Second Affiliated Hospital of Guangzhou Medical University
• RECRUITINGNANCT03017573
  Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)
  Institut Curie

See all trials for Sarcoma of cervix uteri →